Scarica l'app Stockscreener
0.086
22.52%
-0.025
Dopo l'orario di chiusura:
.08
-0.006
-6.98%
Petros Pharmaceuticals Inc Borsa (PTPI) Ultime notizie
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
3 Penny Stocks to Watch Now, 3/27/25 - TipRanks
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket - Benzinga
"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, - openPR
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? - Yahoo Finance
Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance
Petro-Victory Energy Corp Announces Extension to US $1,700,000 Note - Yahoo Finance
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Yahoo Finance
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Yahoo Finance
Innovations In Medical Technology And Materials Drive Advancements In Erectile Dysfunction Treatments: Key ... - WhaTech
EXCLUSIVE: MIRA Pharmaceuticals Signs To Acquire SKNY Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking Cessation Drug - Yahoo Finance
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Petros Pharmaceuticals enters collaboration with big data, analytics firm - MSN
Petros Pharmaceuticals enhances Rx-to-OTC switch technology By Investing.com - Investing.com South Africa
Petros Pharmaceuticals enhances Rx-to-OTC switch technology - Investing.com
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - ACCESS Newswire
Petros Pharmaceuticals Targets $38B Self-Care Market with Game-Changing AI Drug Platform - StockTitan
PTPI stock plunges to 52-week low of $0.07 amid market challenges By Investing.com - Investing.com South Africa
PTPI stock plunges to 52-week low of $0.07 amid market challenges - Investing.com Australia
Nvidia GTC 2025: What to expect from Nvidia's biggest event of the year - Yahoo Finance
PTPI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now - Yahoo Finance
Petro-Victory Energy and BlueOak Investments to acquire Capixaba Energia - Yahoo Finance
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - Yahoo Finance
Entrada Therapeutics, Inc. Just Beat EPS By 55%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA(R) (Avanafil) Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy - ACCESS Newswire
Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More - Yahoo Finance
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022 - ACCESS Newswire
New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy - ACCESS Newswire
Petros Pharmaceuticals stock hits 52-week low at $0.1 By Investing.com - Investing.com South Africa
Petros Pharmaceuticals stock hits 52-week low at $0.1 - Investing.com
Artificial Intelligence (AI) News Live Feed - StockTitan
Petros reports success in AI-assisted Rx-to-OTC study - Investing.com India
Petros reports success in AI-assisted Rx-to-OTC study By Investing.com - Investing.com South Africa
Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study - ACCESS Newswire
Can Petros Pharmaceuticals' AI-Powered Platform Revolutionize the $38B Self-Care Market? - StockTitan
BioCryst Pharmaceuticals Inc (BCRX) Q4 2024 Earnings Call Highlights: Strong ORLADEYO Revenue ... - Yahoo Finance
Recursion Pharmaceuticals, Inc. (RXRX): The Best Performing Pharma Stock So Far in 2025? - Yahoo Finance
PTPI Page Not Found - Benzinga
Why Viking Therapeutics Inc. (VKTX) Surged On Friday? - Yahoo Finance
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025 - Yahoo Finance
Petros Pharmaceuticals announces pricing of $9.6 million public offering - MSN
Form 424B4 Petros Pharmaceuticals, - StreetInsider.com
PTPI stock plunges to 52-week low of $0.15 amid market challenges - Investing.com India
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings - Benzinga
Watsco, Septerna, Nike - TradingView
Petros Pharmaceuticals Prices $9.6 Million Public Offering of Shares, Warrants -February 18, 2025 at 09:52 am EST - Marketscreener.com
US Stocks Mixed; NY State Business Activity Rises In February - Benzinga India
Petros Pharmaceuticals sets public offering at $0.24 per share - Investing.com
Petros Pharmaceuticals prices 40M shares at 24c in public offering - TipRanks
Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants - ACCESS Newswire
Major Capital Raise: Petros Pharmaceuticals Locks $9.6M Financing DealStrategic Move or Dilution Risk? - StockTitan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire
3.70%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):